10% Owner Sells $16.36M in Silence Therapeutics Shares Near 52-Week High
SLN has more than doubled off its 52-week low of $4.19.
Summary
A 10% owner, Richard Ian Griffiths, sold over $16.3 million worth of Silence Therapeutics ADSs across multiple transactions, reducing his stake while the stock trades near its 52-week high.
Key Events · Ownership and Investor Activity · SLN
-
Significant Insider Sale
Richard Ian Griffiths, a 10% owner, sold 1,544,374 American Depositary Shares (ADSs) for a total of $16,362,815.06.
-
Stake Reduction
These sales represent approximately 13.06% of his prior holdings, reducing his post-transaction ownership to 10,281,486 shares.
-
Timing Near 52-Week High
The transactions occurred between June 29 and July 6, 2026, while Silence Therapeutics' stock was trading near its 52-week high of $11.0599.
Analysis · SLN · Life Sciences
Richard Ian Griffiths, a 10% owner, executed significant sales of American Depositary Shares (ADSs) totaling over $16.3 million. These sales represent approximately 3.27% of the company's market capitalization and occurred over several days, coinciding with the stock trading near its 52-week high. While 10% owners often sell for portfolio rebalancing, the substantial size of these transactions, especially following recent positive clinical data and the activation of an At-The-Market offering program, could be interpreted negatively by the market as a lack of conviction at current price levels.
How filings like this one have moved
In the 30 days to Nov 4, 2026, 32.4% of the 2199 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SLN was trading at $10.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $499.7M. The 52-week trading range was $4.19 to $11.06. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.